Global Heart Transplant Market Size and Forecast 2023-2032|Optum Inc., Novartis Pharmaceuticals UK Ltd., Abbott Laboratories, Medtronic PLC, Stryker Corporation,

The Business Research Company’s Heart Transplant Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Heart Transplant Global Market Report 2023 evaluates heart transplant market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=12967&type=smp

The global heart transplant market is expected to grow from the heart transplant market size has grown rapidly in recent years. It will grow from $10.4 billion in 2023 to $11.49 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to medical advancements, increased awareness and education, advancements in organ preservation, healthcare infrastructure.The heart transplant market size is expected to see strong growth in the next few years. It will grow to $16.45 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%.

The prevalence of cardiovascular diseases is expected to propel the growth of the heart transplant market going forward. Cardiovascular diseases are a range of conditions that affect the heart and blood arteries. A heart transplant is a last-resort treatment for people with end-stage heart failure who have not responded to other treatments. It improves quality of life and extends life expectancy. For instance, in March 2022, according to the Office for National Statistics, a UK-based national statistical authority, the number of deaths due to heart attacks was 20,061 in 2021, increasing from 19,440 in 2020. Further, in May 2023, the Centers for Disease Control and Prevention., a US-based national public health agency, reported that in the US, 1 in 20 adults age 20 and older have cardiovascular diseases, and 695,000 people were suffering from cardiovascular diseases in 2021 and 375,476 people died with cardiovascular diseases that same year. Therefore, the prevalence of cardiovascular diseases will drive the heart transplant market.

Get More Information On The Heart Transplant Market Report:

https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

The heart transplant market segments in the report are:

1) By Surgery Type: Total Artificial Heart, Biventricular Pacing, Ventricular Assist Devices, Other Surgery Types

2) By Transplant: Autograft, Allograft, Other Transplants

3) By End-User: Hospitals, Cardiac Institutes, Other End-Users

The table of contents in TBRC’s heart transplant market report includes:

1. Executive Summary

2. Heart Transplant Market Characteristics

3. Heart Transplant Market Trends And Strategies

4. Heart Transplant Market – Macro Economic Scenario

5. Global Heart Transplant Market Size and Growth

.

.

.

26. South America Heart Transplant Market

27. Brazil Heart Transplant Market

28. Middle East Heart Transplant Market

29. Africa Heart Transplant Market

30. Heart Transplant Market Competitive Landscape And Company Profiles

Top Major Players:

  • Optum Inc
  • Novartis Pharmaceuticals UK Ltd
  • Abbott Laboratories
  • Medtronic PLC
  • Stryker Corporation

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model